These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28749250)

  • 21. Viriditoxin Stabilizes Microtubule Polymers in SK-OV-3 Cells and Exhibits Antimitotic and Antimetastatic Potential.
    Su M; Zhao C; Li D; Cao J; Ju Z; Kim E; Jung YS; Jung JH
    Mar Drugs; 2020 Aug; 18(9):. PubMed ID: 32867174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
    Dumontet C; Jaffrezou JP; Tsuchiya E; Duran GE; Chen KG; Derry WB; Wilson L; Jordan MA; Sikic BI
    Bull Cancer; 2004 May; 91(5):E81-112. PubMed ID: 15568225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
    Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
    Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymoquinone inhibits microtubule polymerization by tubulin binding and causes mitotic arrest following apoptosis in A549 cells.
    Acharya BR; Chatterjee A; Ganguli A; Bhattacharya S; Chakrabarti G
    Biochimie; 2014 Feb; 97():78-91. PubMed ID: 24113316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LG308, a Novel Synthetic Compound with Antimicrotubule Activity in Prostate Cancer Cells, Exerts Effective Antitumor Activity.
    Qin M; Peng S; Liu N; Hu M; He Y; Li G; Chen H; He Y; Chen A; Wang X; Liu M; Chen Y; Yi Z
    J Pharmacol Exp Ther; 2015 Dec; 355(3):473-83. PubMed ID: 26377911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer cells acquire mitotic drug resistance properties through beta I-tubulin mutations and alterations in the expression of beta-tubulin isotypes.
    Cheung CH; Wu SY; Lee TR; Chang CY; Wu JS; Hsieh HP; Chang JY
    PLoS One; 2010 Sep; 5(9):e12564. PubMed ID: 20838440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells.
    Mukhtar E; Adhami VM; Sechi M; Mukhtar H
    Cancer Lett; 2015 Oct; 367(2):173-83. PubMed ID: 26235140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance.
    Toner AP; McLaughlin F; Giles FJ; Sullivan FJ; O'Connell E; Carleton LA; Breen L; Dunne G; Gorman AM; Lewis JD; Glynn SA
    Br J Cancer; 2013 Oct; 109(8):2131-41. PubMed ID: 24052043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
    Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
    Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel synthetic analog of 5, 8-disubstituted quinazolines blocks mitosis and induces apoptosis of tumor cells by inhibiting microtubule polymerization.
    Tian W; Qin L; Song Q; He L; Ai M; Jin Y; Zhou Z; You S; Long Y; Yu Q
    PLoS One; 2010 May; 5(5):e10499. PubMed ID: 20463925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of tubulin polymerization and induction of mitotic blockage by Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H-benzo[d]imidazole-5-carboxylate (MBIC) in human cervical cancer HeLa cell.
    Hasanpourghadi M; Karthikeyan C; Pandurangan AK; Looi CY; Trivedi P; Kobayashi K; Tanaka K; Wong WF; Mustafa MR
    J Exp Clin Cancer Res; 2016 Mar; 35():58. PubMed ID: 27030360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane.
    Azarenko O; Okouneva T; Singletary KW; Jordan MA; Wilson L
    Carcinogenesis; 2008 Dec; 29(12):2360-8. PubMed ID: 18952594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer.
    Ahn S; Hwang DJ; Barrett CM; Yang J; Duke CB; Miller DD; Dalton JT
    Cancer Chemother Pharmacol; 2011 Feb; 67(2):293-304. PubMed ID: 20383708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells.
    Choi M; Kim W; Cheon MG; Lee CW; Kim JE
    Cancer Lett; 2015 Feb; 357(2):591-601. PubMed ID: 25524551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear Lamin A/C Expression Is a Key Determinant of Paclitaxel Sensitivity.
    Smith ER; Leal J; Amaya C; Li B; Xu XX
    Mol Cell Biol; 2021 Jun; 41(7):e0064820. PubMed ID: 33972393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules.
    Di Cesare E; Verrico A; Miele A; Giubettini M; Rovella P; Coluccia A; Famiglini V; La Regina G; Cundari E; Silvestri R; Lavia P
    Oncotarget; 2017 Mar; 8(12):19738-19759. PubMed ID: 28160569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.
    Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE
    Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells.
    Podolski-Renić A; Banković J; Dinić J; Ríos-Luci C; Fernandes MX; Ortega N; Kovačević-Grujičić N; Martín VS; Padrón JM; Pešić M
    Eur J Pharm Sci; 2017 Jul; 105():159-168. PubMed ID: 28502672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
    Cai P; Lu P; Sharom FJ; Fang WS
    Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel tubulin-targeted cell penetrating antimitotic octapeptide.
    Bhunia D; Mohapatra S; Kurkute P; Ghosh S; Jana B; Mondal P; Saha A; Das G; Ghosh S
    Chem Commun (Camb); 2016 Oct; 52(85):12657-12660. PubMed ID: 27713939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.